ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,372Medicare Part D Prescriptions Filled, Including Refills

Rank: 64 out of 625

$710K Total Retail Price of All Prescriptions

Rank: 87 out of 625

492 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 492 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 11,448 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
LEVOTHYROXINE SODIUM 651 559 1 3
SIMVASTATIN 600 511 2 2
AMLODIPINE BESYLATE 447 395 3 1
FUROSEMIDE 438 398 4 7
OMEPRAZOLE 418 391 5 6
HYDROCODONE-ACETAMINOPHEN 347 241 S3 6 4
LISINOPRIL 339 276 7 5
ATORVASTATIN CALCIUM 334 264 8 9
PRAVASTATIN SODIUM 312 289 9 8
SERTRALINE HCL 261 227 10 26
METOPROLOL TARTRATE 247 227 11 11
MELOXICAM 241 207 12 31
POTASSIUM CHLORIDE 235 202 13 19
HYDROCHLOROTHIAZIDE 226 183 14 12
METOPROLOL SUCCINATE 216 171 15 15
METFORMIN HCL ER 216 176 15 41
WARFARIN SODIUM 208 202 17 20
TRAMADOL HCL 199 155 18 16
ZOLPIDEM TARTRATE 187 157 19 13
LOSARTAN POTASSIUM 173 137 20 18
RANITIDINE HCL 140 130 21 25
CITALOPRAM HBR 138 123 22 24
ATENOLOL 138 121 22 22
ALENDRONATE SODIUM 136 131 24 34
CELEBREX 135 128 25 72
PANTOPRAZOLE SODIUM 130 118 26 44
AMITRIPTYLINE HCL 128 120 R 27 61
ENALAPRIL MALEATE 128 101 27 81
METFORMIN HCL 124 97 29 10
VENLAFAXINE HCL ER 121 93 30 86
CRESTOR 102 95 31 17
DIGOXIN 101 98 32 55
CYCLOBENZAPRINE HCL 101 58 R 32 65
AZITHROMYCIN 97 69 34 40
FLUTICASONE PROPIONATE 94 68 35 32
EVISTA 92 72 36 130
DONEPEZIL HCL 89 89 37 33
SYNTHROID 88 58 38 39
KLOR-CON M20 86 82 39 47
CARVEDILOL 85 82 40 23
GLIPIZIDE XL 84 68 41 83
ESCITALOPRAM OXALATE 81 58 42 67
NEXIUM 79 53 43 21
GLIPIZIDE ER 77 70 44 68
GLIMEPIRIDE 75 75 45 42
LOSARTAN-HYDROCHLOROTHIAZIDE 73 66 46 38
LANTUS 71 69 47 54
FLUOXETINE HCL 71 58 47 62
ADVAIR DISKUS 71 67 47 63
ZETIA 68 58 50 66
LIPITOR 68 58 50 75
GABAPENTIN 67 41 52 14
CLONIDINE HCL 67 55 52 50
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 36 54 27
TRICOR 65 65 55 118
BENAZEPRIL HCL 64 61 56 35
GLIPIZIDE 59 58 57 56
MECLIZINE HCL 58 58 58 113
FENOFIBRATE 57 52 59 59
JANUVIA 56 51 60 74
AMLODIPINE BESYLATE-BENAZEPRIL 55 46 61 48
DIOVAN 55 55 61 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 19, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.